SEC Form 4 · accession 0001140361-15-025378
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julian P. Kirk
Director
Period of report
Jun 24, 2015
Accepted (ET)
Jun 25, 2015 · 9:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $5.44 | Jun 24, 2015 | A | 36,000 | A | — | Jun 24, 2025 | Common Stock | 36,000 | 36,000 | D |
Explanation of responses
- F1This option is exercisable with respect to 18,000 shares immediately upon the date of grant and exercisable with respect to the remaining 18,000 shares on the one-year anniversary of the date of grant.